CTRI/2014/02/004438已完成4 期
MIRENA for Contraception In InDian Subjects User continuAtion and Satisfaction Study - MIDAS
Bayer Zydus Pharma Private Ltd0 个研究点目标入组 600 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •Â· Subject aged between 18-49 years who are initiating LNG IUS
- •therapy for contraception
- •Â· Subject willing to provide informed consent and comply with study
排除标准
- •Â· Exclusion criteria must be read in conjunction with the local product
- •information.
- •The decision to initiate use of a LNG IUS for contraception is made
- •independently by the participant and her health care provider and is
- •not mandated by study design or protocol.
研究者
相似试验
已完成
不适用
MIRENA for Contraception In InDian Subjects User continuAtion and Satisfaction Study: MIDAS StudyContraceptionNCT01961375Bayer600
已完成
不适用
Family planning methods in the Republic of Moldova in relation to unintended pregnancyISRCTN10397992icolae Testemi?anu State University of Medicine and Pharmacy600
进行中（未招募）
不适用
A comparison of Mirena use in women with and without fibroids - Mirena and FibroidsMenorrhagiaEUCTR2011-001461-40-GBHull and East Yorkshire Acute Hospitals NHS Trust
尚未招募
4 期
Annovera Acceptability StudyPACTR202312652733486The Population Council Inc NY USA400
进行中（未招募）
1 期
Continuous Oral contraceptives versus Lucrin before IVF/ICSI in EndometriosisThe research population consists of women with surgically confirmed endometriosis ASRM stage III or IV or endometrioma on transvaginal ultrasound or MRI, scheduled for an IVF/ICSI treatment.EUCTR2016-004545-91-NLVU University Medical Center, department of reproductive Medicine330